---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-056586"
form_type: "8-K"
ticker: "GALT"
cik: "0001133416"
company_name: "GALECTIN THERAPEUTICS INC"
filed_at: "2023-12-07T23:59:59+00:00"
generated_at: "2026-06-07T16:00:50.323564+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Galectin Therapeutics presents at annual meeting; transcript content not fully disclosed in filing

## Summary
- Presentation after Annual Meeting of Stockholders on December 7, 2023.
- Furnished transcript begins with a forward-looking statements disclaimer; no specific updates visible.
- No financial results, product milestones, or material announcements are contained in the available exhibit portion.

## SEC filing metadata
- accession: 0001140361-23-056586
- form_type: 8-K
- ticker: GALT
- cik: 0001133416
- company_name: GALECTIN THERAPEUTICS INC
- filed_at: 2023-12-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133416/000114036123056586/0001140361-23-056586-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133416/000114036123056586/ef20016222_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-056586
- JSON: https://secwatch.observer/filing/0001140361-23-056586.json
- Plain text: https://secwatch.observer/filing/0001140361-23-056586.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.